SETS Enterprises would like to introduce two new products to the COVID Pandemic Response designed with the purpose to support and integrate together, the Gardian T3 – Saliva Rapid Antigen Test and Gardian Self Check App – offering an increase in both the accuracy and early detection of COVID-19, whilst providing stronger controls to track, prompt, measure and report personnel.
What is the Gardian T3 Saliva Rapid Antigen Test?
Not all rapid antigen tests are created equally
Gardian T3 Saliva Self Test is designed for ease of use – the simple one-step process used in conjunction with the Gardian Self Check App effectively removes human error, ensuring the test is administered the right way, every time.
TGA-approved to a very high level of specificity and sensitivity, the Gardian T3 Saliva Self Test has proven efficient across Alpha, Beta, Gamma, Delta, Kappa and Omicron variants. Capable of detecting in the earliest stages of infection while delivering a reportable result within 10 Minutes.
Specifically, Gardian T3 COVID-19 SARS-CoV-2 Antigen Saliva Self Test is a qualitative lateral flow immunoassay intended to detect SARS-CoV-2 nucelocapsid antigens present in human saliva samples in vitro.
More than a test kit
Where Gardian T3 helps define itself as a leading option for accurate and efficient self testing, is the benefit of integrated proprietary software. Designed to operate safely and securely from a mobile device, the app based software allows sites and work forces to validate and verify every test performed. Supported by a unique ID on each test kit, auditable testing data can be shared and reported immediately.
Want to learn more?
